0001562180-22-000356.txt : 20220107
0001562180-22-000356.hdr.sgml : 20220107
20220107211831
ACCESSION NUMBER: 0001562180-22-000356
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220106
FILED AS OF DATE: 20220107
DATE AS OF CHANGE: 20220107
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Clark George C.
CENTRAL INDEX KEY: 0001878290
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38080
FILM NUMBER: 22519452
MAIL ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Biohaven Pharmaceutical Holding Co Ltd.
CENTRAL INDEX KEY: 0001689813
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
BUSINESS PHONE: 203-404-0410
MAIL ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2022-01-06
false
0001689813
Biohaven Pharmaceutical Holding Co Ltd.
BHVN
0001878290
Clark George C.
C/O BIOHAVEN PHARMACEUTICALS, INC.
215 CHURCH STREET
NEW HAVEN
CT
06510
false
true
false
false
VP, Chief Accounting Officer
Common Shares
2022-01-06
4
M
false
875.00
0.00
A
9115.00
D
Common Shares
2022-01-06
4
F
false
409.00
123.86
D
8706.00
D
Common Shares
2022-01-07
4
M
false
1000.00
0.00
A
9706.00
D
Common Shares
2022-01-07
4
F
false
522.00
128.87
D
9184.00
D
Restricted Share Unit Award
2022-01-06
4
M
false
875.00
0.00
D
Common Shares
875.00
1750.00
D
Employee Stock Option (right to buy)
128.87
2022-01-07
4
A
false
10000.00
0.00
A
2032-01-07
Common Shares
10000.00
10000.00
D
Restricted Share Unit Award
2022-01-07
4
A
false
5000.00
0.00
A
Common Shares
5000.00
5000.00
D
Restricted Share Unit Award
2022-01-07
4
M
false
1000.00
0.00
D
Common Shares
1000.00
4000.00
D
No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units.
Each restricted share unit represents the contingent right to receive one common share of the Issuer.
The reporting person was granted 3,500 restricted share units on January 6, 2021, vesting in four equal installments on January 6, 2021, 2022, 2023 and 2024, subject to the reporting person's continued service with the Issuer at each vesting date.
Not applicable.
The shares underlying this option vest in four equal installments on January 7, 2022, 2023, 2024 and 2025, subject to the reporting person's continuous service with the Issuer at each vesting date.
The reporting person was granted 5,000 restricted share units on January 7, 2022, vesting in four equal installments on January 7, 2022, 2023, 2024 and 2025, subject to the reporting person's continued service with the Issuer at each vesting date. 100% of these restricted share units are generally subject to settlement in 10 equal annual installments after separation from service.
/s/ George Clark
2022-01-07